That is why it would have been important to keep infection rates down until there's a vaccine - because it is more than likely now that there's a strain of coronavirus somewhere that has a different spike protein and so is not caught by the existing vaccines.
Normally we should have sampled a number of strains with fewer of the same mutations, shouldn't we?
That would make sense, if it was the 17th mutation that (possibly together with the rest of the mutations) gave it this advantage.